Utilization Management Program-Preauthorization Update Effective May 1, 2021 for All Lines of Business that Require Preauthorization
We would like to share updates with you regarding preauthorization under our Utilization Management (UM) Program.
New Dental Record Requirements Grid Available Online
We are excited to share with you that we have a new grid available on our website to help you determine when we require dental records to consider or approve a claim for payment.
COVID-19 Treatment with Monoclonal Antibodies
The U.S. Food and Drug Administration issued an emergency use authorization for investigational monoclonal antibody therapies bamlanivimab and casirivimab/imdevimab for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adult and pediatric patients.
Partnering to achieve the quality of care provided to our members and communities.